News

The FDA elevated a recall of intraocular lenses currently being wrapped up by Bausch + Lomb, following increased reports of ...
The Peninsula The pioneering procedure signals a major advancement in personalized eye care and surgical innovation in the ...
The demand for intraocular lenses is experiencing significant growth, driven by the rising prevalence of eye diseases, increased government efforts worldwide to prevent and treat blindness, ...
IOL leverages Pure Refractive Optics Technology, featuring a continuous refractive surface across the optical diameter.
AI-powered imaging tools are now capable of detecting early signs of conditions such as diabetic retinopathy, glaucoma and ...
Monofocal and multifocal lenses are both types of artificial intraocular lens (IOL). A monofocal lens has one focusing distance, whereas a multifocal lens can focus on close and far distances at ...
Patients with astigmatism above 1.5 D or against-the-rule astigmatism had significantly less residual astigmatism with toric ...
Bausch + Lomb has received a CE mark for its Luxlife intraocular lens, the company said Wednesday. The CE mark positions ...
Bausch + Lomb announced today that it received CE mark approval for its LuxLife full range of vision intraocular lens (IOL).
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced CE Mark approval for the LuxLife full range of ...